ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,487.03
      0.25%
      US Tech 100
      19,430.40
      0.14%
      Dow Jones
      38,834.86
      0.15%
      Brent Oil
      84.705
      -0.09%
      Bitcoin
      65,274.14
      0.21%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mesoblast Limited (MESO)

      7. Mesoblast Limited (MESO) News

      MESO

      Mesoblast (MESO)

      Mesoblast Limited
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MESO
      DateTimeSourceHeadlineSymbolCompany
      08/27/20196:36PMGlobeNewswire Inc.Mesoblast to Host Analyst Call on 2019 Financial Results for Year and Fourth Quarter Ended June 30, 2019NASDAQ:MESOMesoblast Limited
      08/27/20196:00AMGlobeNewswire Inc.FDA Provides Guidance on Clinical Pathway to Marketing Application for Revascor in End-Stage Heart Failure Patients With an L...NASDAQ:MESOMesoblast Limited
      08/19/20196:05AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      08/14/20196:00AMGlobeNewswire Inc.Remestemcel-L to be Evaluated as Treatment for Chronic Graft Versus Host Disease in Planned Investigator-Initiated TrialNASDAQ:MESOMesoblast Limited
      08/13/20196:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      08/12/20196:00AMGlobeNewswire Inc.Mesoblast Appoints Leading Pharmaceutical Industry Executive as Chief Medical OfficerNASDAQ:MESOMesoblast Limited
      08/02/20196:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      07/31/20196:00AMGlobeNewswire Inc.Mesoblast Quarterly Cash Flow ReportNASDAQ:MESOMesoblast Limited
      07/30/20196:01AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      07/25/20196:00AMGlobeNewswire Inc.Circulation Research Special Article Highlights Potential Of Mesoblast Cell Therapy In Treatment Of Advanced Heart FailureNASDAQ:MESOMesoblast Limited
      07/17/20196:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      06/24/20196:00AMGlobeNewswire Inc.Mesoblast Heart Failure Cell Therapy Receives Orphan Drug Designation From FDA for Prevention of Gastrointestinal Bleeding in...NASDAQ:MESOMesoblast Limited
      06/19/20196:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      06/18/20196:00AMGlobeNewswire Inc.High Economic Burden in Children With Steroid Refractory Acute Graft Versus Host DiseaseNASDAQ:MESOMesoblast Limited
      06/14/20191:44PMGlobeNewswire Inc.UPDATE - Mesoblast to Host Virtual Symposium With Key Opinion Leader Highlighting Acute Graft Versus Host DiseaseNASDAQ:MESOMesoblast Limited
      06/14/201910:28AMGlobeNewswire Inc.Mesoblast to Host Virtual Symposium With Key Opinion Leader Highlighting Acute Graft Versus Host DiseaseNASDAQ:MESOMesoblast Limited
      06/12/20196:05AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      06/11/20196:00AMGlobeNewswire Inc.Mesoblast and JCR Pharmaceuticals Expand Japan License Agreement to Use of Mesenchymal Stem Cells in Newborns With Insufficie...NASDAQ:MESOMesoblast Limited
      06/03/20196:13AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      06/03/20196:10AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      05/31/20196:14AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      05/30/20197:09PMGlobeNewswire Inc.Mesoblast Reports Financial Results and Operational Highlights for the Period Ended March 31, 2019NASDAQ:MESOMesoblast Limited
      05/30/20196:00AMGlobeNewswire Inc.Mesoblast Financial Results Webcast for Period Ended March 31, 2019NASDAQ:MESOMesoblast Limited
      05/29/20198:49PMGlobeNewswire Inc.Mesoblast Initiates Rolling Submission of Biologics License Application (BLA) to U.S. FDA for remestemcel-L in the Treatment ...NASDAQ:MESOMesoblast Limited
      05/29/20196:10AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      05/23/20196:00AMGlobeNewswire Inc.Mesoblast Keynote Presentations to Feature at 2019 Annual Meeting of the International Society for Cell and Gene TherapyNASDAQ:MESOMesoblast Limited
      05/21/20196:04AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      05/17/20196:00AMGlobeNewswire Inc.Mesoblast to Present at 2019 RBC Capital Markets Global Healthcare ConferenceNASDAQ:MESOMesoblast Limited
      05/06/20196:09AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
      04/23/20196:10AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:MESOMesoblast Limited
       Showing the most relevant articles for your search:NASDAQ:MESO